Cosette pharmaceuticals launches betaine anhydrous powder, ab-rated to cystadane® (betaine anhydrous for oral solution)

Bridgewater, n.j.--(business wire)-- #alembic--cosette pharmaceuticals, inc. ("cosette") has obtained the us marketing rights to betaine anhydrous for oral solution 180gm (“betaine”) in an agreement with ani pharmaceuticals, inc. (nasdaq: anip) and commenced shipping (ndc #0713-0352-81) to customers this week.
ANIP Ratings Summary
ANIP Quant Ranking